skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Biomedtracker’s Q2 2021 Catalyst Roundup

Access your free, data-packed infographic to see the outcomes for two select drugs highlighted in Biomedtracker’s and Meddevicetracker’s Q2 Outlook Report and their:

  • Q2 catalysts
  • PMA supplemental approval decision
  • Study supporting EPI-sense system insights
  • 5-day stock performance following the catalysts
  • Notable upcoming catalysts for the device
MDT Q3 Outlook Report

Q3 2021 Outlook Report Extract

What major drug catalysts and events can you expect to see in the months ahead? Download your free extract from the Q3 2021 Outlook Report to find out. Shape your strategy with your inside look at what’s to come.

The full report includes:

  • Data for 27 drugs, diagnostics, and devices
  • Likelihood of Phase/PDUFA review success for each
  • Q3 expected large impact catalysts
  • A look back at the outcomes from the Q2 Outlook report
  • Overall Likelihood of Approval (LOA) based on phase, drug class, and disease group

 

Purchase the full Q3 2021 Outlook Report from the Report Store

Q3 Outlook Report Extract

Read also

;

Next steps

Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: